Follitropin beta

Drug Profile

Follitropin beta

Alternative Names: Follistim; Follistim AQ Cartridge; ORG-32489; Puregon; Recombinant human follicle-stimulating hormone - Organon; rh-FSH - Organon

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Female infertility; Hypogonadism

Most Recent Events

  • 28 Feb 2017 Merck has patent protection for follitropin beta in the US, Europe and Japan (Merck Annual report 2016)
  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
  • 19 Nov 2007 Organon was acquired by Schering-Plough
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top